Dupilumab Improves Outcomes for EoG in Phase 2 Clinical Trial

11-center CEGIR network study led by Cincinnati Children's advances our understanding of eosinophilic gastritis – a rare inflammatory food allergic disease of the stomach – and potentially opens promising avenues for development of new therapeutic approaches. CINCINNATI, June 29, 2026...